Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.86)
# 3,905
Out of 4,981 analysts
323
Total ratings
25.35%
Success rate
-27.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGEN Agenus | Reiterates: Buy | $23 | $4.48 | +413.39% | 20 | Sep 10, 2025 | |
| AGIO Agios Pharmaceuticals | Reiterates: Buy | $56 | $36.77 | +52.30% | 2 | Sep 4, 2025 | |
| BCTX BriaCell Therapeutics | Maintains: Buy | $32 → $40 | $8.00 | +400.00% | 15 | Aug 27, 2025 | |
| INKT MiNK Therapeutics | Upgrades: Buy | $35 | $14.40 | +143.06% | 14 | Aug 15, 2025 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $36 | $19.76 | +82.19% | 2 | Aug 13, 2025 | |
| FEMY Femasys | Maintains: Buy | $12 → $8 | $0.39 | +1,940.30% | 25 | Aug 11, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $5 → $4 | $0.84 | +379.04% | 12 | Aug 7, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $10 → $9 | $2.12 | +324.53% | 2 | Jul 22, 2025 | |
| RAPT RAPT Therapeutics | Maintains: Buy | $6 → $27 | $16.27 | +66.00% | 2 | Jul 10, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Buy | $40 → $20 | $2.43 | +723.05% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $5.40 | +567.20% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $76.19 | +50.94% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $12 | $2.56 | +368.75% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $38 | $23.40 | +62.39% | 10 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.77 | +286.10% | 20 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.22 | +241.61% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $10.70 | +2,516.82% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.56 | +412.82% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.08 | +476.92% | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.95 | +659.49% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.52 | +1,150.00% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.97 | +813.71% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $5.75 | +3,075.83% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.84 | +733.53% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.27 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $11.52 | +108.33% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.20 | +1,400.00% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.30 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $12.15 | +212.76% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.57 | +5,684.40% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.83 | - | 1 | Apr 25, 2024 |
Agenus
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $4.48
Upside: +413.39%
Agios Pharmaceuticals
Sep 4, 2025
Reiterates: Buy
Price Target: $56
Current: $36.77
Upside: +52.30%
BriaCell Therapeutics
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $8.00
Upside: +400.00%
MiNK Therapeutics
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $14.40
Upside: +143.06%
vTv Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $36
Current: $19.76
Upside: +82.19%
Femasys
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.39
Upside: +1,940.30%
Context Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.84
Upside: +379.04%
SAB Biotherapeutics
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $2.12
Upside: +324.53%
RAPT Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $6 → $27
Current: $16.27
Upside: +66.00%
Jasper Therapeutics
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $2.43
Upside: +723.05%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $5.40
Upside: +567.20%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $76.19
Upside: +50.94%
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $2.56
Upside: +368.75%
Jun 4, 2025
Upgrades: Buy
Price Target: $22 → $38
Current: $23.40
Upside: +62.39%
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $7.77
Upside: +286.10%
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $3.22
Upside: +241.61%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $10.70
Upside: +2,516.82%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.56
Upside: +412.82%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $2.08
Upside: +476.92%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $3.95
Upside: +659.49%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.52
Upside: +1,150.00%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.97
Upside: +813.71%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $5.75
Upside: +3,075.83%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.84
Upside: +733.53%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $11.52
Upside: +108.33%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $1.20
Upside: +1,400.00%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.30
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $12.15
Upside: +212.76%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.57
Upside: +5,684.40%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.83
Upside: -